GSK hits back at 60 Minutes whistleblower interview
January 6, 2011Manufacturing and Production 60 Minutes, Avandamet, Bactroban, Cheryl Eckard, GSK, GlaxoSmithKline, Kytril, Paxil, manufacturing compliance
GlaxoSmithKline has responded to an edition of US current affairs show 60 Minutes centring on manufacturing problems at its now-closed …
BMS appoints Dr Veronique Walsh
January 5, 2011Sales and Marketing BMS, Bristol-Myers Squibb, Dr Véronique Walsh, appointment, sales and marketing
Bristol-Myers Squibb UK has appointed Dr Véronique Walsh as business unit director, neuroscience and immunoscience . She joins the company …
Merck KGaA opens outsourcing centre in India
January 5, 2011Research and Development Application and Technology Centre, India, Merck KGaA, Merck Millipore, Millipore, outsourcing
Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …
Contract research news in brief
January 5, 2011Research and Development Accel Synthesis, Almac, Bioanalytical Systems, Caliper Life Sciences, Cambridge Research & Instrumentation, Critical Path Services, Pharmasset, ReSearch Pharmaceutical Services, ResourcingPoint, Warburg Pincus
Private equity firm Warburg Pincus buys RPS for $227 million, plus updates from BASi, Almac, Caliper, and Critical Path Services/Accel …
Flu ad campaign dusted off as cases rise
January 5, 2011Medical Communications NHS, UK, disease awareness, flu, influenza
The Department of Health this week relaunched its advertising campaign to remind people of the importance of good hand and …
NHS faces its toughest ever year
January 5, 2011BMA, NHS, NHS Confederation, NHS White Paper, NHS reforms, clinical commissioning
Doctors leaders and healthcare managers have used their New Year messages to warn of hard times in 2011 for the …
EDC is Now – The Changing
January 5, 2011Research and Development
Clinical research is rapidly moving toward the electronic environment as more han half of all studies are conducted utilizing EDC, …
Pfizer pays $63m for generics portfolio
January 5, 2011Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables
Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …
GSK’s Dr Anne Phillips moves to Novo Nordisk
January 4, 2011Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing
Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …
Digital Pharma: First big pharma Android apps launched
January 4, 2011Medical Communications Android, Digital Pharma blog, Novartis, Sanofi-Aventis, apps, ipad, iphone
Big pharma’s smartphone marketing is starting to look beyond Apple’s attention-grabbing iPhone as companies produce the first apps for its …
NICE’s public health role reduced
January 4, 2011NHS, NHS reforms, NICE, public health, quality standards
NICE’s public health remit has been slimmed down as part of the government’s reforms with the removal of six areas …
Working Life: Astellas Pharma Europe’s chief operating officer
January 4, 2011Business Services, Sales and Marketing Astellas, Ken Jones, Working Life, recruitment
Ken Jones tells Pharmafocus about how his field is changing, starting with how he found his way into his current …
Achieve More in Phase I Studies
January 4, 2011Research and Development
Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …
Pharma manufacturing news in brief
January 4, 2011Manufacturing and Production Affinity Life Sciences, American Regent, Caraco Pharmaceutical Laboratories, Dr Reddy's Laboratories, Dr Reddy’s Laboratories, Huanggang Chuangxin Biochemicals, Kunming Quanxin Pharmaceutical Company, R-Pharm
An explosion at a Chinese pharma company causes five deaths, plus a round-up of product recalls, facility updates and other …
Italy: pioneering pay for performance in the age of austerity
January 4, 2011Sales and Marketing Drug pricing, Italy, cancer drug prices, price cuts
2010 saw Europe beset by economic turmoil, as governments have struggled with the effects of the downturn, including considerable public …
Novartis adds R&D unit to new vaccines plant
December 31, 2010Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines
Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …
US healthcare ‘extreme makeover’ predicted for 2011
December 31, 2010Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC
Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …
VTE trial boost for Pfizer and BMS’ apixaban
December 31, 2010Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Pfizer, VTE, apixaban, enoxaparin, venous thromboembolism
Pfizer and Bristol-Myers Squibb’s oral anticoagulant apixaban has shown benefits over a standard injectable treatment for venous thromboembolism in a …
UCB plans €250m plant to meet Cimzia demand
December 29, 2010Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing
Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
